Company Profile

Macrocure Ltd. is a clinical-stage biopharmaceutical company focused on developing a novel therapeutic platform to address chronic and hard-to-heal wounds, such as diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs).

Read More

NASDAQ: MCUR

$ 1.56
- 0.01 (-0.64%)
Day High: 1.60
Day Low:  1.56
Volume:    39,323
3:59 PM ET on Dec 2, 2016

Delayed at least 20 minutes.